Polypharmacy and potentially inappropriate prescribing in people with type 2 diabetes: An analysis of the Scottish Diabetes Research Network national diabetes cohort
The degree of polypharmacy highlights the need for regular formal medication reviews in this population.
Authors
- Helen M. Colhoun (ORCID: https://orcid.org/0000-0002-8345-3288)
- William Berthon (ORCID: https://orcid.org/0000-0003-1776-4798)
- Rory J. McCrimmon (ORCID: https://orcid.org/0000-0002-3957-1981)
- David McAllister (ORCID: https://orcid.org/0000-0003-3550-1764)
- Luke A. K. Blackbourn (ORCID: https://orcid.org/0000-0003-4234-8040)
- Peter Hanlon (ORCID: https://orcid.org/0000-0002-5828-3934)
- L. Walker (ORCID: https://orcid.org/0000-0003-1354-0826)
- Stuart J. McGurnaghan (ORCID: https://orcid.org/0000-0002-3292-4633)
- Amanda Paula Fernandes (ORCID: https://orcid.org/0000-0002-1823-3473)
Institutions
- University of Liverpool (GB)
- University of Dundee (GB)
- Edinburgh Cancer Research (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1111/dme.70179
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Diabetes UK
- Pharmacy Research UK